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Abstract 
Hippocampal neurogenesis continues throughout adult life and potentially plays a 
crucial role in mood and cognitive disorders.  We summarise the preclinical insights and 
potential translational steps that could be taken to investigate the role and importance of 
this phenomenon in disease and health in humans.   
 
Adult hippocampal neurogenesis  
In 1913, Santiago Ramón y Cajal concluded that neurons are exclusively generated 
prenatally, and the notion that no further neurons are produced after birth has remained 
a central dogma within neuroscience. 
 
Within the last decade, this view has been challenged following the demonstration that 
new brain cells are generated within specific neurogenic sites throughout adulthood. 
These are the dentate gyrus of the hippocampus and the subventricular zone1. In 
humans, adult neurogenesis undoubtedly occurs in the hippocampus 2, but its function 
and importance has yet to be convincingly demonstrated because of a paucity of clinical 
studies and lack of a validated measure of new neuron function. Nevertheless, valid 
methods to index neurogenesis are achievable 3, and given the potential of an 
understanding of neurogenesis to advance treatments for mental health disorders, 
psychiatrists should explore this area.  
 
What is adult hippocampal neurogenesis for? 
A model for the function of adult-born neurons in the dentate gyrus is emerging as 
evidence from animal work accumulates 4. With greater excitability and plasticity, new 
neurons in the dentate gyrus can modulate the activity of mature neurons, enhancing 
the ability to learn and discriminate between highly similar contexts in a neural process 
known as pattern separation. This involves successful recall of two distinct memories 
with overlapping features, for example, where you parked your car today versus the 
place you parked it yesterday. By preventing interference between novel and older 
memories, neurogenesis may also enhance the ability to adapt to new contexts where 
old rules are replaced with new associations, as in reversal learning.  
 
Why might neurogenesis be important for psychiatry?  
Impaired neurogenesis would reduce the ability to learn that a new context is safe once 
a stressful situation has finished. A consequent persisting negative emotion, such as 
fear or anxiety, could then plausibly contribute to psychopathology, for example in 
depression, anxiety or post-traumatic stress-disorder. Hence, factors that impair 
neurogenesis in rodents and nonhuman primates, such as chronic stress with 
hypothalamic-pituitary-adrenal axis (HPA) hyperactivity and elevated glucocorticoid 
levels, lead to animal models of depressive behaviours 5. A recent study has 
demonstrated the neurogenesis-inhibition that accompanies cancer chemotherapy and 
the emergence of depressive behaviours in mice 6, explaining the depressive and 
cognitive symptoms  described in chemotherapy patients. Evidence that this may also 
apply to humans includes the neurogenesis-inhibiting effect of glucocorticoids on 
hippocampal stem cells in vitro 7, and the observation that depressed patients perform 
poorly on pattern separation tasks 4, have lower levels of circulating neurogenic factors 
(BDNF) that correlate with symptom severity 8 and reduced newborn hippocampal 
neurons at post-mortem 9. 
  
If impaired neurogenesis can lead to depressive and anxiety symptoms, could its 
recovery underlie antidepressant treatment effects? There is good evidence to suggest 
that this could be the case. Administration of antidepressants are associated with 
increased neurogenesis in rodents, nonhuman primates, human hippocampal stem cells 
in vitro and human post-mortem brain tissue, with some rodent studies finding that 
neurogenesis is necessary for some of the behavioural effects of SSRIs4. Intriguingly, 
the time course of maturation of newly generated neurons in the dentate gyrus generally 
coincides with the time to therapeutic action of antidepressants. Non-pharmacological 
treatments for depression such as electroconvulsive shock therapy and physical 
exercise have also been shown to restore neurogenesis in animals, and human 
performance on a pattern separation task improves after an exercise intervention10. 
 
The observation that adult hippocampal neurogenesis declines with increasing age 
could explain some of the reduced cognitive flexibility and impaired memory 
performance associated with normal ageing, mild cognitive impairment (MCI) and 
neurodegenerative conditions such as Alzheimer disease (AD). Many of the molecular 
players in AD are also modulators of neurogenesis11 and performance on tasks 
designed to test pattern separation ability show an age-MCI-AD continuum12. 
 
Although there is increasing evidence for the role of neurogenesis in mood and 
cognitive disorders, there are some caveats to consider. Any effects of impaired 
neurogenesis are likely to be context-dependent. For example, chronic stress may be 
necessary if depressive behaviours are to arise through this mechanism. Further, 
neurogenesis is likely to be one of several potential mechanisms of antidepressant 
action and may not necessarily underlie all of the behavioural effects of treatment. 
Finally, findings from animals can never be wholly applied to humans, although the 
accumulated evidence provides testable hypotheses that can be translated to human 
studies.   
 
How can neurogenesis be investigated in humans? 
There is currently no method to directly detect and measure hippocampal neurogenesis 
in humans. One strategy to clarify the precise relationship between neurogenesis and 
cognition/mood could involve combination of different correlates of neurogenesis to 
optimise convergent validity. For example, observing within a population whose 
impaired neurogenesis would be expected to recover that these correlates improve in 
accordance with the known maturation time of human hippocampal stem cells (4-8 
weeks)13 would have predictive validity. Demonstration of a temporal dissociation 
between the recovery of putative neurogenesis-dependent correlates and other non-
neurogenesis dependent measures would also be informative. These approaches could 
be nested within clinical trials, for example, in cancer patients after receiving a discrete 
regimen of chemotherapy or depressed patients about to start antidepressant therapy. It 
can be expected that any improvement in mood will be temporally associated with 
improvements in neurogenesis correlates (described below).  
 
A combination of neuropsychology, neuroimaging and biological correlates can 
indirectly measure neurogenesis. Pattern separation tasks are convenient and easy to 
administer tests designed to probe the function of new neurons in different cognitive 
domains, for example emotional, spatial or temporal pattern separation. These can be 
combined and used in conjunction with non-neurogenesis dependent cognitive tasks 
(e.g. episodic and working memory, attention, executive function) to reveal a 
performance dissociation compared to a control group and between two time points 
measured before and after presumed neural stem cell maturation.  
 
The validity of pattern separation tasks as markers for neurogenesis can be tested by 
functioning magnetic resonance imaging (fMRI) to show that performance is associated 
with activity in the dentate gyrus14. The small size of individual hippocampal subfields 
makes them notoriously difficult to delineate and measure, however the increasing 
availability of 7-Tesla MRI scanners could provide insight into dentate gyrus volume 
changes which may be associated with neurogenesis.  
 
Therapeutic implications 
If human studies uncover a role for hippocampal neurogenesis in neuropsychiatric 
disorders, existing treatments and novel neurogenic agents could be prescribed to 
target this process in patients with depression, neurodegenerative conditions and those 
being treated with chemotherapy. Studies investigating neurogenesis can identify 
potentially targetable molecular mechanisms for future antidepressants 7.  Increasingly, 
research is also revealing a possible role for neurogenesis in schizophrenia and drug 
addiction15. Stem-cell based therapies are also on the horizon; impending clinical trials 
for Parkinson’s disease16 may pave a way for future human hippocampal stem cell 
transplants.  
 
Conclusion 
Adult hippocampal neurogenesis represents a new and promising area of enquiry for 
psychiatry, requiring researchers to bridge the translational divide between existing 
animal work and human studies. Better demonstration of the role of this process and its 
therapeutic potential in common neuropsychiatric conditions would lead to a paradigm 
shift in how we assess and manage disorders of cognition and mood in our patients. 
 
 
 
References 
1  Gage FH. Mammalian neural stem cells. Science 2000; 287: 1433–8. 
2  Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, et al. 
Dynamics of hippocampal neurogenesis in adult humans. Cell 2013; 153: 1219–27. 
3  Ho NF, Hooker JM, Sahay A, Holt DJ, Roffman JL. In vivo imaging of adult human 
hippocampal neurogenesis: progress, pitfalls and promise. Mol Psychiatry 2013; 
18: 404–16. 
4  Anacker C, Hen R. Adult hippocampal neurogenesis and cognitive flexibility - 
linking memory and mood. Nat Rev Neurosci 2017. doi:10.1038/nrn.2017.45. 
5  Murray F, Smith DW, Hutson PH. Chronic low dose corticosterone exposure 
decreased hippocampal cell proliferation, volume and induced anxiety and 
depression like behaviours in mice. Eur J Pharmacol 2008; 583: 115–27. 
6  Egeland M, Guinaudie C, Du Preez A, Musaelyan K, Zunszain PA, Fernandes C, et 
al. Depletion of adult neurogenesis using the chemotherapy drug temozolomide in 
mice induces behavioural and biological changes relevant to depression. Transl 
Psychiatry 2017; 7: e1101. 
7  Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, et al. 
Glucocorticoid-related molecular signaling pathways regulating hippocampal 
neurogenesis. Neuropsychopharmacology 2013; 38: 872–83. 
8  Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical 
studies on major depression and BDNF levels: implications for the role of 
neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169–80. 
9  Lucassen PJ, Stumpel MW, Wang Q, Aronica E. Decreased numbers of progenitor 
cells but no response to antidepressant drugs in the hippocampus of elderly 
depressed patients. Neuropharmacology 2010; 58: 940–9. 
10  Déry N, Pilgrim M, Gibala M, Gillen J, Wojtowicz JM, Macqueen G, et al. Adult 
hippocampal neurogenesis reduces memory interference in humans: opposing 
effects of aerobic exercise and depression. Front Neurosci 2013; 7: 66. 
11  Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s 
disease. Mol Neurodegener 2011; 6: 85. 
12  Ally BA, Hussey EP, Ko PC, Molitor RJ. Pattern separation and pattern completion 
in Alzheimer’s disease: evidence of rapid forgetting in amnestic mild cognitive 
impairment. Hippocampus 2013; 23: 1246–58. 
13  Yu DX, Di Giorgio FP, Yao J, Marchetto MC, Brennand K, Wright R, et al. Modeling 
hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Reports 
2014; 2: 295–310. 
14  Liu KY, Gould RL, Coulson MC, Ward EV, Howard RJ. Tests of pattern separation 
and pattern completion in humans-A systematic review. Hippocampus 2016; 26: 
705–17. 
15  DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of 
mental illness: a critical evaluation. Neuropharmacology 2010; 58: 884–93. 
16  Barker RA, Parmar M, Kirkeby A, Björklund A, Thompson L, Brundin P. Are Stem 
Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016? J 
Parkinsons Dis 2016; 6: 57–63. 
 
